Health
Results: 805-816 of 7432

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery

Sepul Bio, an innovative business unit of Théa, Doses First Participant in Phase 3 HYPERION clinical trial of sepofarsen for CEP290-associated Leber Congenital Amaurosis Type 10









